These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14510935)

  • 1. Pulmonary veno-occlusive disease following allogeneic peripheral blood stem cell transplantation for chronic myeloid leukaemia.
    Mukai M; Kondo M; Bohgaki T; Notoya A; Kohno M
    Br J Haematol; 2003 Oct; 123(1):1. PubMed ID: 14510935
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies.
    Konuma T; Kato S; Ishii H; Oiwa-Monna M; Asano S; Tojo A; Takahashi S
    Leuk Res; 2015 Jun; 39(6):625-31. PubMed ID: 25888304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary veno-occlusive disease as a cause for reversible pulmonary hypertension in a patient with multiple myeloma undergoing peripheral blood stem cell transplantation.
    Malhotra P; Varma S; Varma N; Sharma RR; Jain S; Kumari S; Manoj R; Marwaha N
    Am J Hematol; 2005 Oct; 80(2):164-5. PubMed ID: 16184590
    [No Abstract]   [Full Text] [Related]  

  • 4. Early renal injury after nonmyeloablative allogeneic peripheral blood stem cell transplantation in patients with chronic myelocytic leukemia.
    Liu H; Ding JH; Liu BC; Zhao G; Chen BA
    Am J Nephrol; 2007; 27(4):336-41. PubMed ID: 17519537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive chronic graft-versus-host disease of skin successfully treated with thalidomide.
    Nair V; Sharma A; Ghosh I; Arora S; Sahai K; Dutta V
    J Assoc Physicians India; 2005 Nov; 53():988-90. PubMed ID: 16515241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic blood stem cell transplantation in advanced chronic myeloid leukemia--high response rate associated with increased chronic graft-versus-host disease.
    Sayer HG; Kasper C; Mügge LO; Schilling K; Scholl S; Höffken K
    Haematologica; 2003 Jul; 88(7):831-3. PubMed ID: 12857566
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac morbidity in advanced chronic myelogenous leukaemia patients treated by successive allogeneic stem cell transplantation with busulphan/cyclophosphamide conditioning after imatinib mesylate administration.
    Sohn SK; Kim JG; Kim DH; Lee KB
    Br J Haematol; 2003 May; 121(3):469-72. PubMed ID: 12716370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic peripheral blood and bone marrow stem cell transplantation for chronic myelogenous leukemia: single center study from Iran.
    Ghavamzadeh A; Iravani M; Jabehdar-Maralani P; Hajrasouliha A; Tavakoli S
    Haematologica; 2003 Apr; 88(4):ELT13. PubMed ID: 12681990
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary veno-occlusive disease following reduced-intensity cord blood transplantation.
    Gutman JA; Allen CT; Madtes DK; Schramm J; Delaney C
    Bone Marrow Transplant; 2008 Oct; 42(8):559-61. PubMed ID: 18641679
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of splenectomy on pancytopenia after a peripheral blood stem cell transplantation.
    Ding J; Bao W; Wang J; Zhao G; Chen J; Song H
    Cell Transplant; 2011; 20(7):1109-15. PubMed ID: 21092413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic cell transplantation in systemic mastocytosis: is there a high risk for veno-occlusive disease?
    Ustun C; Smith A; Cayci Z; Courville EL; Corbacioglu S; Akin C; Horny HP; Valent P; Devine S; Weisdorf DJ
    Eur J Haematol; 2016 Jun; 96(6):655-7. PubMed ID: 26679533
    [No Abstract]   [Full Text] [Related]  

  • 12. Mobilization of autologous hematopoietic progenitors and subsequent transplantation is a safe and feasible procedure in chronic phase chronic myelogenous leukemia patients with cytogenetic resistance to imatinib.
    Prebet T; Tigaud I; Hayette S; Clapisson G; Philip I; Michallet M; Nicolini FE
    Haematologica; 2005 Nov; 90 Suppl():ECR36. PubMed ID: 16266927
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
    Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Veno-occlusive Disease that Developed Following Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
    Takeda K; Naito A; Sugiura T; Ishige M; Shikano K; Abe M; Kasai H; Miyakuni S; Yamashita S; Shigeta A; Sakao S; Suzuki T
    Intern Med; 2023 Jan; 62(2):275-279. PubMed ID: 35705278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed tomography findings in a patient with severe graft-versus-host disease of the gut.
    Tan DC; Koh LP; Tan PH
    Br J Haematol; 2007 Mar; 136(6):768. PubMed ID: 17129228
    [No Abstract]   [Full Text] [Related]  

  • 17. Salmonella enteritidis septic arthritis after allogeneic peripheral blood stem cell transplantation.
    Matsubara H; Kobayashi M; Tokumasu M; Nakanishi H; Miyazaki M; Mizushima Y; Hiramatsu H; Adachi S; Nakayama T; Onishi E; Nakahata T
    Leuk Lymphoma; 2006 Jul; 47(7):1435-7. PubMed ID: 16923588
    [No Abstract]   [Full Text] [Related]  

  • 18. Alloimmune hepatitis following peripheral stem cell transplantation.
    Habib S; Nalesnik MA; Ahmad J; BuchBarker D; Shakil AO
    Bone Marrow Transplant; 2007 May; 39(9):573-5. PubMed ID: 17369864
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune hemolysis after fludarabine-based reduced intensity conditioning and allogeneic PBSC transplantation for CML with minor ABO incompatibility.
    Calixto R; Ostronoff F; Ostronoff M; Sucupira A; Florêncio R; Maior AP; Domingues MC; Chandrasekaran V
    Ann Hematol; 2012 Feb; 91(2):295-7. PubMed ID: 21559812
    [No Abstract]   [Full Text] [Related]  

  • 20. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells.
    Becker PS; Wagle M; Matous S; Swanson RS; Pihan G; Lowry PA; Stewart FM; Heard SO
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):45-9. PubMed ID: 9209740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.